Invitation to media, investor and analyst call for Medicover Q2 report 2019

Medicover’s (MCOV B) interim report April-June 2019 will be published on 26 July at 07.45 CEST.

The Company will hold a conference call (in English) for media, financial analysts and investors on 26 July at 09.30 CEST.

CEO Fredrik Rågmark and CFO Joe Ryan will present the report and take questions.

Shortly before the webcast, presentation slides will be available on our website.

To join the conference call please dial-in using the following details at least 10 minutes before the start of the call:

Sweden: +46 (0) 850 692 180

UK: +44 (0) 2071 928 000

Germany: +49 (0) 3022 1531 802

Code: 3178888

A live audio webcast of the conference call will be available at:

For further information, please contact:

Hanna Bjellquist, Head of Investor Relations

Phone: +46 703 033 272


Medicover is a leading international healthcare and diagnostic services company and was founded in 1995. Medicover operates a large number of ambulatory clinics, hospitals, specialty-care facilities and laboratories and the largest markets are Poland and Germany. In 2018, Medicover had revenue around €672 million and 20,970 employees. For more information, go to

About Us

Medicover is a leading international healthcare and diagnostic services provider in Poland, Germany, Romania, Ukraine and certain other markets, primarily in Central and Eastern Europe (“CEE”). Additionally, Medicover is in the process of entering the fast-growing Indian healthcare market in order to expand its geographical footprint and further leverage its emerging markets capabilities. Medicover offers a broad range of healthcare services and a significant hub-and-spoke diagnostic laboratory network, supported by extensively developed proprietary software and information systems infrastructure. Medicover operates through two divisions: Healthcare Services and Diagnostic Services.